ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc (SNOA)

0.192
0.0235
(13.95%)
Closed June 19 4:00PM
0.177
-0.015
(-7.81%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.177
Bid
0.177
Ask
0.18
Volume
79,489,222
0.186 Day's Range 0.2998
0.1159 52 Week Range 1.25
Market Cap
Previous Close
0.1685
Open
0.2689
Last Trade Time
Financial Volume
$ 17,351,790
VWAP
0.218291
Average Volume (3m)
2,628,642
Shares Outstanding
15,607,433
Dividend Yield
-
PE Ratio
-0.61
Earnings Per Share (EPS)
-0.33
Revenue
13.27M
Net Profit
-5.15M

About Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of ther... Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
1970
Sonoma Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNOA. The last closing price for Sonoma Pharmaceuticals was $0.17. Over the last year, Sonoma Pharmaceuticals shares have traded in a share price range of $ 0.1159 to $ 1.25.

Sonoma Pharmaceuticals currently has 15,607,433 shares outstanding. The market capitalization of Sonoma Pharmaceuticals is $3.12 million. Sonoma Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.61.

SNOA Latest News

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M

SNOA Discussion

View Posts
tw0122 tw0122 22 hours ago
SNOA .36
πŸ‘οΈ0
tw0122 tw0122 22 hours ago
SNOA hit .24
πŸ‘οΈ0
glenn1919 glenn1919 1 day ago
SNOA...........................https://stockcharts.com/h-sc/ui?s=SNOA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
CanItBThisEZ2Make CanItBThisEZ2Make 4 weeks ago
Upcoming Events ---->
https://sonomapharma.com/sonoma-events-tradeshows/

GO $SNOA
👍️ 1
CanItBThisEZ2Make CanItBThisEZ2Make 4 weeks ago
Investor Presentation From April 9, 2024 ---->
https://d1io3yog0oux5.cloudfront.net/_f4a411dced9e94f2fedfb7f057423722/sonomapharma/db/359/2900/pdf/Sonoma+Presentation+4.9.24+Website+Version.pdf

GO $SNOA
👍️ 1
The Night Stalker The Night Stalker 1 month ago
bottom
πŸ‘οΈ0
TheFinalCD TheFinalCD 5 months ago
.16-.25

$1.7M OFFERING @ .20
https://dilutiontracker.com/app/search/SNOA
πŸ‘οΈ0
OffTheGrid OffTheGrid 6 months ago
😁
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
SNOA new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
SNOA new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
SNOA new 52 week low
πŸ‘οΈ0
The Night Stalker The Night Stalker 12 months ago
hmmm
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
dip;
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
Coming back around Cool
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
SNOA: Hey, Cpt. T-N!!! (I indeed DID get your PM, but --- since I no longer have a subscription to that --- I can only reply to you right here. In any event, THANKS Bro for your heads-up!!)

And let's get this Big Dog FLYIN'!!!!
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
Continuing higher from PM
πŸ‘οΈ0
alchemytrader alchemytrader 1 year ago
There is no other symbol. The other one is s private company.
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
$SNOA being confused with a different Sonoma regarding $REGN deal— t.k. (@tcarm1) March 28, 2023
πŸ‘οΈ0
zj3001 zj3001 1 year ago
The other is private company partnering with REGN
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
WHATS THE OTHER SYMBOL?
πŸ‘οΈ0
alchemytrader alchemytrader 1 year ago
people chased off news from the WRONG TICKER...lol
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
https://finviz.com/quote.ashx?t=SNOA&p=d
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Nice premarket gap up
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Nice AH move
πŸ‘οΈ0
Toddrobertking Toddrobertking 1 year ago
Sonoma Pharmaceuticals managed to land one serious new customer: the United States government. Sonoma’s Microcyn Rx line of products now have a DAPA, or a Distribution and Pricing Agreement. This opens up their use for the Defense Logistics Agency. This also gives Sonoma’s partner, EMC Pharma, the ability to offer Microcyn Rx products to its own customers in the U.S. government. Half of EMC Pharma’s customer base is U.S. government entities. That, in turn, likely means a nice shot in the profits for Sonoma’s partner firm.
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
OS only 3+milly
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Buy 2’s up!
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
2.68 finally broke $2.44 without meeeeeeeeee

#ARRRRRRRRG

after taking it down to 1.88
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
im out with profits on the fail to break new ni
πŸ‘οΈ0
resx18 resx18 1 year ago
Good Morning $SNOA
👍️ 1
TheFinalCD TheFinalCD 1 year ago
break 2.44 run to 2.75+
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
trying again for 2.44
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
$SNOA watch for 2.44 break tried 2x already
πŸ‘οΈ0
tw0122 tw0122 1 year ago
$2.10 Ran to quick for me might have to pass unless it pulls back some 2.2 million float could do more wonders.
Good luck
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
$SNOA https://twitter.com/algobotnews/status/1618227346275794944

https://finviz.com/quote.ashx?t=SNOA&ty=c&ta=1&p=d
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 years ago
3M os lets see how it goes https://finviz.com/quote.ashx?t=SNOA&ty=c&ta=1&p=d
πŸ‘οΈ0
subslover subslover 2 years ago
Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States
Download as PDFOctober 27, 2022
BOULDER, CO / ACCESSWIRE / October 27, 2022 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care and dermatological conditions, today announced that it has launched Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel and Rejuvacyn® Advanced Skin Repair Cooling Mist direct to consumers for over-the-counter use in the United States.

Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel is a new direct to consumer version of a product previously only available by prescription. Reliefacyn alleviates symptoms such as red bumps, itchy, painful and scaly rashes, shallow skin fissures and peeling, and effectively manages symptoms of eczema/atopic dermatitis. Reliefacyn supports the three phases of healing (inflammation, proliferation and remodeling), and the gel adheres quickly to the skin, making it easy to apply without dripping or running. Reliefacyn is antipruritic, anti-inflammatory, and anti-allergic.

Rejuvacyn® Advanced Skin Repair Cooling Mist is intended for over-the-counter management of minor skin irritations following cosmetic procedures as well as daily skin health and hydration. Formulated to enhance the body's natural healing process, Rejuvacyn aids in recovery following common procedures performed at dermatologists' offices and medical spas such as microdermabrasion, laser treatments, injections, facials, and chemical peels. Rejuvacyn is safe to use around the nose, mouth, and eyes, with a cool mist application that soothes the skin. Rejuvacyn® Advanced Skin Repair Cooling Mist has also been certified as a Natural Personal Care Product by the Natural Products Association.

"We are excited to expand our line of dermatology products to create a portfolio of consumer-focused products that provide healing and relief for common conditions and procedures. We've also formulated Rejuvacyn as an all-natural product for consumers who want to avoid potentially harmful additives in their healthcare regime. Our products will be immediately available through our website, and through third-party distributors," said Amy Trombly, CEO of Sonoma Pharmaceuticals.

For more information about these products, visit https://sonomapharma.com/dermatology-new. You can order Reliefacyn or Rejuvacyn on our website at https://otc.sonomapharma.com or by contacting our customer service department at 720-452-9690 or customerservice@sonomapharma.com.

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, and dermatological conditions. The company's products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company's products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Boulder, Colorado with manufacturing operations in Guadalajara, Mexico. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com. For partnership opportunities, please contact busdev@sonomapharma.com.

Forward-Looking Statements

Except for historical information herein, matters set forth in this press release are forward-looking within
πŸ‘οΈ0
stocktrader306 stocktrader306 2 years ago
been a long time since i visited this board. but i'm still accumulating SNOA!!! hoping some news comes to do what it did last August !????????????????
πŸ‘οΈ0
wile.e.coyote wile.e.coyote 2 years ago
lo floater on news .....
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
So,so news. No $ contracts announced. News catalyst for day trade.
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
does SNOA ran more on this hand sanitizer news, hold or fall back?


πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
Going straight up!
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
$SNOA news is nothing special but the float already traded in premarket. Could be a serious squeeze here— M K (@pennystockpickz) October 15, 2021
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
I noticed your first on the scene for a lot of these runners. Congrats !
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
O/s 2.09m short float 39%
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
Could be a huge runner today
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
Sonoma Pharma, MicroSafe Report Nanocyn Disinfectant, Sanitzer Has Been Approved By Australia Therapeutic Goods Admin.
7:04 am ET October 15, 2021 (Benzinga) Print
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its partner, the MicroSafe Group, announce that the Australian Therapeutic Goods Administration (TGA) has approved extended claims for Nanocyn® Disinfectant and Sanitizer, which is manufactured by Sonoma for its partner MicroSafe using Sonoma’s patented Microcyn® Technology.

After original approval by the TGA and entry into The Australian Register Of Therapeutic Goods for use against SARS-CoV-2 (COVID 19) in mid-2020, the TGA has now approved extended claims for the hard-surface disinfectant Nanocyn® with a 15 second kill time against common viruses, including SARS-CoV-2, Norovirus (Gastro), and influenza, and a 30-second kill contact time against common bacteria, such as Staphylococcus aureus (MRSA), E. coli, Pseudomonas aeruginosa, fungi and mold - including Candida Albicans.

β€œNanocyn® is a game-changer for any hospital, aged care or health care facility, transportation-provider, business, school, tourism or hospitality venue wanting to ensure their premises are COVID-safe, not just from a pandemic point of view, but also the comfort that comes with using a non-toxic disinfectant that does not leave any harmful residues behind,” said MicroSafe Group CEO Safa Qadumi.

In addition, Nanocyn® had been previously certified by major aviation manufacturers. The product can disinfect aircraft without damaging sensitive materials. It is also the only TGA registered hospital grade disinfectant of its kind to be certified by Good Environmental Choice Australia (GECA).

Bruce Thornton, Chief Operating Officer of Sonoma Pharmaceuticals stated, β€œWe could not be more excited about making our safe and effective Microcyn® Technology available to valued partners such as MicroSafe. We are continuously seeking to add to our network of international distributors to increase the reach of Sonoma products worldwide.”

πŸ‘οΈ0